The DOI matches its Crossref record; 84 of the 94 references it cites were found in a registry or an index; 7 of the 23 sources its claims cite were checked for support.
Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature
Open accessAbstract
Hypothyroidism is a frequently diagnosed endocrine disorder. Common signs and symptoms include fatigue, cold intolerance, hoarseness, dry skin, constipation, a slow relaxation phase of deep tendon reflexes, and bradycardia. However, some patients may exhibit atypical signs and symptoms, which can result in diagnostic confusion. Pituitary hyperplasia resulting from longstanding primary hypothyroidism was first described by Niepce in 1851. It is usually asymptomatic, but sometimes, in addition to symptoms of overt hypothyroidism, patients may complain of headaches, hypopituitarism, visual field impairment, and hyperprolactinemia. Furthermore, on imaging, pituitary hyperplasia can be mistaken for a pituitary adenoma. Distinguishing between the two is crucial, as their management differs; the former often responds to thyroid hormone replacement therapy, while the latter might need treatment with surgery and/or radiotherapy. Here we describe a patient who developed pituitary hyperplasia in the setting of longstanding uncompensated primary hypothyroidism due to a lack of compliance with levothyroxine replacement therapy. We also review the clinical, laboratory, and radiologic findings of the case reports available in the literature up to now in order to improve the knowledge and the care of the disease.
Overview
CoChat Summary
TL;DR
This paper reports a 22-year-old woman with pituitary hyperplasia due to longstanding uncompensated primary hypothyroidism and reviews 93 adult cases published since 1996. It emphasizes that pituitary hyperplasia can mimic adenoma but usually regresses with levothyroxine, so recognition can avoid unnecessary neurosurgery.
Key findings
The new case was a 22-year-old female with a 20-mm intra/infra/suprasellar lesion, TSH >300 µIU/mL, fT3 1.4 ng/L, fT4 4.5 ng/L, PRL 25.7 µg/L, and alpha subunit 1.6 mIU/mL; after weekly levothyroxine 1000 μg, TSH normalized after 3 weeks and MRI at 5 and 12 months showed significant volumetric reduction, avoiding neurosurgery.
- The review included 93 adult cases (20 M; median age 32, IQR 24.5, range 18–83 years). Median TSH at diagnosis was 33.5 (104) × ULN (n = 67), median PRL was 1.6 (2.3) × ULN (n = 73); hyperprolactinemia was present in 69.1% (56/81), hypopituitarism in 23.9% (11/46), and visual field alteration in 37.5% (32).
- Imaging: pituitary hyperplasia was initially interpreted as pituitary adenoma in 58.6% (34/58); suprasellar extension was found in 96.5% (56/58), optic chiasm compression in 70.4% (38/54), and nipple/dome sign in 66.7% (24/36). Median maximal mass diameter was 16.5 (7) mm (n = 40); median mass volume was 900 (979) mm³ (n = 59).
- Treatment/outcome: most patients were treated by initiating or adjusting levothyroxine, while 11 were referred for neurosurgery. Follow-up MRI (n = 77) showed complete regression in 55, partial resolution in 17, stability in 4, and further increase in 1; the discussion reports complete resolution in 71.4% and at least a decrease in 22.1%. TSH normalized in 35/49, reduced in 5, and remained elevated in 9; PRL was normal in 28/37 and still elevated in 9.
Methods
Case report plus comprehensive literature review; PubMed and EMBASE were searched from January 1996 to December 2023 for adult human cases of pituitary hyperplasia in primary hypothyroidism, English only, with reference lists and key reviews also examined.
- Inclusion required overt primary hypothyroidism, TSH at diagnosis, and pituitary lesion characteristics; exclusions were non-CT/MRI imaging, pediatric cases, mean-only hormonal/size data, and conference abstracts. Two investigators independently extracted data, resolving discrepancies by consensus.
- Statistical analysis used Shapiro–Wilk normality testing; non-normal and categorical data were presented as median (IQR) or counts/percentages; Wilcoxon, Kruskal-Wallis, and Spearman tests were used in MedCalc v20.007. TSH and PRL were expressed as × upper limit normal (ULN).
Limitations
The paper states that publication bias may overestimate the frequency of rare symptoms, that the nipple sign was explicitly documented in text for only four patients with remaining cases inferred from imaging review, and that it is unknown whether long-standing milder TSH elevation in subclinical hypothyroidism can cause pituitary hyperplasia.
- The paper also notes missing data across case reports: alpha-subunit levels and TRH testing were reported in only five patients, hormonal follow-up was available in 60%, and MRI follow-up in 86%.
- Evident from the text: many analyses rely on small subsets, no significant correlation was found between TSH × ULN and pituitary dimensions at diagnosis, and heterogeneity across case reports and hormonal assays limits generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
6 Valid · 1 Not valid · 12 Not checked · 49 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The presentation and imaging may resemble that of a pituitary tumor: patients may exhibit symptoms of hypothyroidism [8], as well as hyperprolactinemia, headaches, and, in some cases, visual field defects if the enlarged pituitary gland compresses the optic chiasm.”
§ Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature > 1. Introduction
What the sources say
- Supportedcites [8] Chaker, 2017, Hypothyroidism, Lancet source
The citation is attached to the statement that patients may have symptoms of hypothyroidism, rather than to the preceding imaging comparison. In “Myxedema coma and severe hypothyroidism” (page unavailable), the paper says severe primary hypothyroidism can cause pituitary hyperplasia and describes associated symptoms. (LLM, conf=0.87)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Since 1996, 93 clinical cases (20 M; age, median 32 (IQR 24.5) years, range 18–83 years) of pituitary hyperplasia due to longstanding PH in adult subjects have been described in the English literature, including our patient.”
§ Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature > 3. Results > 3.2. Comprehensive Review
states a causen = 93- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, very rare symptoms such as ovarian hyperstimulation syndrome [16,32,33,59,62,64] or psychosis [28,38], as well as pseudoacromegaly [20,37], were also reported.”
§ Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature > 4. Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Some degree of hypopituitarism was reported in 23.9% (n = 11/46) of cases.”
§ Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature > 3. Results > 3.2. Comprehensive Review
plainn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In 58.6% (n = 34/58) of cases, pituitary hyperplasia was initially interpreted as a pituitary adenoma.”
§ Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature > 3. Results > 3.2. Comprehensive Review
plainn = 34- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 68 claims and every source verdict.
- It may state two separate claims as one. 36
- Probably not a substantial claim. 9
Citations
Cites
Thyroid Function and Human Reproductive Health
Krassas, G. E., Poppe, K., & Glinoer, D. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0041 · Cited by 1,223 · cited 1×
“…suggests that multicystic ovaries may arise from a disproportionate increase in FSH levels coupled with decreased luteinizing hormone (LH) concentrations, attributed to alterations in gonadotropin-releasing hormone (GnRH) pulse frequency mediated by elevated TRH levels in hypothyroid patients [66].”
BackgroundChaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053 · cited 3×
“Common signs and symptoms include asthenia, lethargy, cold sensitivity, rough voice, dry skin, constipation, a slow relaxation phase of deep tendon reflexes, and decreased heart rate [1].”
BackgroundInfluentialChatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide
Bowers, C. Y., Friesen, H. G., Hwang, P., Guyda, H. J., & Folkers, K. (1971) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(71)90441-4 · Cited by 407 · cited 1×
“Elevated TRH levels can induce hyperplasia of both thyrotrophs and lactotrophs, leading to heightened PRL levels and an enhanced PRL response following intravenous TRH infusion [46,73,76,79].”
BackgroundSpectrum of Pituitary Alteration with Mild and Severe Thyroid Impairment* †
BIGOS, S. T., RIDGWAY, E. C., KOURIDES, I. A., & MALOOF, F. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-2-317 · Cited by 185 · cited 2×
“Elevated TRH levels can induce hyperplasia of both thyrotrophs and lactotrophs, leading to heightened PRL levels and an enhanced PRL response following intravenous TRH infusion [46,73,76,79].”
BackgroundSerum prolactin levels in untreated primary hypothyroldism
Honbo, K. S., Van Herle, A. J., & Kellett, K. A. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90517-x · Cited by 173
Bauer, M., Silverman, D. H. S., Schlagenhauf, F., London, E. D., Geist, C. L., Herle, K. V., Rasgon, N., Martinez, D., Miller, K., Herle, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2235 · Cited by 153 · cited 1×
“While the precise mechanism remains incompletely understood, both T4 and T3 play crucial roles in preserving proper neuronal conduction and cerebral blood flow [69,70].”
BackgroundThyrotropin-Secreting Pituitary Tumors
Samuels, M. H. (1997) · Humana Press eBooks · doi:10.1007/978-1-4612-3954-3_15 · Cited by 125
Research works printed but not linked: 2
- Persani, 1996, Thyrotropin-secretingpituitarytumors, Endocr. Rev., 17, 610
- Melmed, S.A., Goldfine, A., Koenic, R., and Rosen, C. (2020). Williams Textbook of Endocrinology, Elsevier. [14th ed.].
Cited by
Du, S.-N., Sun, J., Wang, C., Zhou, Y., Zhao, H., Li, W., & Chen, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1601190 · Cited by 1
Steroid Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT): Correspondence
Elwadhi, A., & Paharia, K. (2025) · The Indian Journal of Pediatrics · doi:10.1007/s12098-025-05455-4 · Cited by 1
Case Report: Development of a thyrotropinoma in a patient with thyroid hemiagenesis
Rozenek, E. B., Gurnell, M., Kunicki, J., Maksymowicz, M., Korbonits, M., Zgliczyński, W., & Stelmachowska‐Banaś, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1902011
“This suggests that, apart from the absolute TSH concentration, other factors may also play a role, such as individual pituitary sensitivity to TRH and the duration of stimulation (20).”
Could iodine be the missing micronutrient in breast cancer development?
Liu, J., Zhou, X., Xu, Y., Zhou, Y., & Sun, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1674237
Tovar, A. P., Lizcano-Aros, J. A., & Martínez, W. A. R. (2025) · Clinical & Translational Metabolism · doi:10.1007/s12018-025-09316-8
Metadata
- Authors
- Roux, A., Rosso, D., Cuboni, D., Maccario, M., Grottoli, S., Arvat, E., & Gasco, V.
- Affiliations
- University of Turin (IT)
- Corresponding author
- Gasco, Valentina
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2024-06-19
- Volume
- 12
- Issue
- 6
- Pages
- 1368
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC11202140
- OpenAlex
- W4399802379
- Cited by
- 9
- References
- 94
- Citations by year
- 2026: 4 · 2025: 5
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Keywords
- pituitary hyperplasia, primary hypothyroidism, hypopituitarism, hyperprolactinemia, pituitary adenoma differential diagnosis, thyroid hormone replacement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature. https://app.cochat.ai/papers/10.3390/biomedicines12061368
- The paper
- Roux, A., Rosso, D., Cuboni, D., Maccario, M., Grottoli, S., Arvat, E., & Gasco, V. (2024). Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature. Biomedicines. https://doi.org/10.3390/biomedicines12061368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.